MGeneRx is an Artificial Intelligence platform developed by rare disease experts, physicians and engineers that can instantly identify a child’s risk for congenital birth defects using biometric recognition

MGeneRX is an Artificial Intelligence platform developed by rare disease experts, physicians and engineers that can instantly identify a child’s risk for congenital birth defects using biometric recognition

With over 7,000 identified genetic disorders, current common newborn DNA tests only detect approximately 20 of them. We are working to address this, by providing cost effective screening for pediatric patients

Working to reduce parent’s stress and anxiety, we offer instant results, enabling the identification of the presence of a genetic condition and early referral to specialized care. With these capabilities, we help medical professionals to reduce high clinical costs whilst opening opportunities for outreach to rural areas and communities who struggle to find access to genetisist’s who specialize is these disorders

The product has been used and tested on thousands of children from 28 different countries. This has extended our capabilities to spot conditions in a global population.

  • Using the camera on your phone or device, the MGeneRX application uses a simple interface to detect newborn genetic disorders

  • Pictures are taken of a newborn or infant’s face and then digitally compared to the software’s models

  • Instantly, results are provided to indicate whether a child is at high, medium or low risk for a congenital birth defect

Our AI Platform currently has close to 90% accuracy in detecting 128 syndromes, including

DiGeorge
Syndrome

Down
Syndrome

Williams Syndrome

Noonan
Syndrome

Using machine learning, we have also discovered new facial landmarks for syndromes previously unknown – continuing our output of expanding clinical knowledge

With over 7,000 identified genetic disorders, current common newborn DNA tests only detect approximately 20 of them. We are working to address this, by providing cost effective screening for pediatric patients

Working to reduce parent’s stress and anxiety, we offer instant results, enabling the identification of the presence of a genetic condition and early referral to specialized care. With these capabilities, we help medical professionals to reduce high clinical costs whilst opening opportunities for outreach to rural areas and communities who struggle to find access to genetisist’s who specialize is these disorders

The product has been used and tested on thousands of children from 28 different countries. This has extended our capabilities to spot conditions in a global population.

  • Using the camera on your phone or device, the MGeneRX application uses a simple interface to detect newborn genetic disorders

  • Pictures are taken of a newborn or infant’s face and then digitally compared to the software’s models

  • Instantly, results are provided to indicate whether a child is at high, medium or low risk for a congenital birth defect

Our AI Platform currently has close to 90% accuracy in detecting 128 syndromes, including

 

DiGeorge
Syndrome

Down
Syndrome

Williams Syndrome

Noonan
Syndrome

Using machine learning, we have also discovered new facial landmarks for syndromes previously unknown – continuing our output of expanding clinical knowledge

Ready to Learn More?

WOULD YOU LIKE TO BE A PART OF OUR ENDEAVOR TO ADDRESS GENETIC DISORDERS?

Contact Us